Medizinische Universität Graz - Research portal
SHR
Neuro
Cancer
Cardio
Metab
Microb
Lipid
Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood
- Local Subprojectlead:
- Speicher Michael
- Duration:
- 01.02.2015-31.12.2019
- Programme:
- EU (FP-7)
- Subprogramme
- 11th Call Innovative Medicines Initiative
- EU-Project Instruments
- Collaborative Project (Large-Scale Integrating Project)
- Type of Research
- applied research
- Staff
- Speicher, Michael, Project Leader
- MUG Research Units
- Diagnostic and Research Institute of Human Genetics
- Project partners
- Alacris Theranostics GmbH, Germany
- Bayer Schering Pharma AG, Germany
- Boehringer Ingelheim International GmbH, Germany
- Charite Universitätsmedizin Berlin, Germany
- Department of Paediatric Oncology, Institut Marie Curie, Paris, France
- Deutsches Krebsforschungszentrum Stiftung, Germany
- Eli Lilly and Company Ltd, United Kingdom
- European organisation for research and treatment of cancer, Belgium
- GABO:MI Gesellschaft für Ablauforganisation:Milliarium mbH & Co KG, Germany
- GILUPI GmbH, Germany
- Heinrich Heine University, Germany
- Institut de Recherches Servier, France
- Institute Gustave Roussy, France
- Instituto Oncologico Veneto IRCCS, Italy
- Integrated Biobank of Luxembourg Foundation, Luxembourg
- Leukocare AG, Germany
- Max Planck Society, Germany
- National and Kapodistrian University of Athens, Greece
- ORION Corporation, Finland
- Oslo University Hospital, Norway
- Siemens Healthcare Diagnostics Products GmbH, Germany
- Slicon Biosystems, Italy
- TATAA Biocenter AB, Sweden
- The Chancellor, Masters and Scholars of the University of Cambridge, United Kingdom
- Universita degli studi di Torino, Italy
- Universitair Medisch Centrum Groningen, Netherlands
- Universitätsklinikum Hamburg-Eppendorf, Germany
- Université de Montpellier, France
- University of Manchester, United Kingdom
- University of Twente, Netherlands
- VyCAP BV, Netherlands